Literature DB >> 17715288

Novel mutation in splicing donor of dystrophin gene first exon in a patient with dilated cardiomyopathy but no clinical signs of skeletal myopathy.

Shigemi Kimura1, Makoto Ikezawa, Shiro Ozasa, Kaori Ito, Hiroe Ueno, Kowashi Yoshioka, Saki Ijiri, Keiko Nomura, Kyoko Nakamura, Makoto Matuskura, Teruhisa Miike.   

Abstract

One cause of X-linked dilated cardiomyopathies is mutation of the dystrophin gene. We report the case of a young boy who suffered from dilated cardiomyopathy caused only by dystrophin-deficient cardiac muscle, but who did not present with any clinical signs of skeletal myopathy. Sequence analysis of the patient's dystrophin gene revealed the presence of a novel single point mutation at the first exon-intron boundary, inactivating the 5' splice site consensus sequence of the first intron. The lack of muscle weakness observed clinically can be explained by expression of the brain and Purkinje dystrophin isoforms in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17715288     DOI: 10.1177/0883073807304705

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  5 in total

1.  Rare variant mutations identified in pediatric patients with dilated cardiomyopathy.

Authors:  Evadnie Rampersaud; Jill D Siegfried; Nadine Norton; Duanxiang Li; Eden Martin; Ray E Hershberger
Journal:  Prog Pediatr Cardiol       Date:  2011-01-01

2.  Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle.

Authors:  DeWayne Townsend; Soichiro Yasuda; Sheng Li; Jeffrey S Chamberlain; Joseph M Metzger
Journal:  Mol Ther       Date:  2008-04-15       Impact factor: 11.454

3.  The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy.

Authors:  Marcella Neri; Emanuele Valli; Giovanna Alfano; Matteo Bovolenta; Pietro Spitali; Claudio Rapezzi; Francesco Muntoni; Sandro Banfi; Giovanni Perini; Francesca Gualandi; Alessandra Ferlini
Journal:  BMC Med Genet       Date:  2012-03-28       Impact factor: 2.103

4.  Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation.

Authors:  Shigemi Kimura; Kowasi Yoshioka
Journal:  Sci Rep       Date:  2014-06-11       Impact factor: 4.379

5.  Clinical Genetic Testing for the Cardiomyopathies and Arrhythmias: A Systematic Framework for Establishing Clinical Validity and Addressing Genotypic and Phenotypic Heterogeneity.

Authors:  John Garcia; Jackie Tahiliani; Nicole Marie Johnson; Sienna Aguilar; Daniel Beltran; Amy Daly; Emily Decker; Eden Haverfield; Blanca Herrera; Laura Murillo; Keith Nykamp; Scott Topper
Journal:  Front Cardiovasc Med       Date:  2016-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.